Surgical Team: UTSW team, including:

• Dr. Jeff Kenkel
• Dr. Abby Culver

Cases: 34 patients (68 Breasts)

• Breast 1: Brijjit as Final Closure
• Breast 2: Suture

Outcomes with Brijjit:

• 91% Reduction in Wound Breakdown
• 38% Reduction in Mean Scar Area

• Lead Surgeon: Dr. Jeff Lawrence
• Comparison (placed above final suture layer): Brijjit vs. 2-Octyl Cyanoacrylate Based Skin Glues

Cases:

• 438 with Brijjit
• 400 with glue/tape

Preliminary Outcomes with Brijjit:

• 0 Allergic Rreactions
• 0 PJIs
• 0 Superficial SSIs
• 0 Wound Breakdown / Dehiscence
• 0 Readmission / Reoperation

Study expected completion in 2026

• Lead Surgeon: Dr. Andy Grotting
• Comparison (placed above final suture layer): Brijjit vs. 2-Octyl Cyanoacrylate Based Skin Glues

Cases: 85 with Brijjit

• 130 lower extremity
• 7 upper extremity

Preliminary Outcomes with Brijjit:

• 0 Allergic Reactions
• 0 Superficial SSIs
• 0 Wound Breakdown / Dehiscence
• 0 Readmission / Reoperation

Study expected completion in 2026

• Lead Surgeon: Dr. Holly Wall

Cases: 121 patients with Brijjit (242 Breasts)

• Breast 1: Suture + Brijjit
• Breast 2: Suture

Outcomes with Brijjit:

• 89% Reduction in Wound Breakdown

• Lead Surgeon: Dr. David Kazmer
• Method: Engineering Analysis

Outcomes with Brijjit:

• Up to 100% Tension Offloading at and Below the Skin Surface

A lab tested analysis of the speed associated with using traditional sutures to close vs using the revolutionary new BRIJ Medical's force modulating